Navigation Links
VioQuest Pharmaceuticals to Present at the Paramount BioSciences Healthcare Conference
Date:10/19/2007

Keynote Luncheon Address by James Cornelius, CEO of Bristol-Myers Squibb

BASKING RIDGE, N.J., Oct. 19 /PRNewswire-FirstCall/ -- VioQuest Pharmaceuticals (OTC Bulletin Board: VQPH) today announced that Daniel Greenleaf, President and Chief Executive Officer of VioQuest Pharmaceuticals, will be presenting at the Paramount BioSciences Healthcare Conference on Tuesday, October 23, at 10:45 a.m. EDT at the Waldorf Astoria Hotel in New York City. Mr. Greenleaf will provide a company overview and update on the status of VioQuest's current clinical development programs.

Those who are interested in attending may visit http://www.paramountbio.com/hcare2007 to register. Or, contact Ms. Tara Crosson of Paramount BioSciences at tcrosson@paramountbio.com or (212) 554-4351.

About VioQuest Pharmaceuticals

VioQuest focuses on acquiring, developing, and commercializing targeted late preclinical and early clinical stage therapies with unique mechanisms of action primarily for oncology and infectious diseases. VioQuest has three targeted drug candidates in clinical development: VQD-002 which inhibits activation of Akt that is seen at abnormally high levels in breast, ovarian, colorectal, pancreatic, and hematologic cancers; Lenocta(TM), an inhibitor of specific protein tyrosine phosphatases (PTPases), SHP-1 and SHP-2, which has shown compelling clinical and biological activity in solid tumors and Xyfid(TM), a topical therapy which has shown early clinical promise in the treatment and prevention of chemo-induced Hand-Foot Syndrome (HFS). VioQuest anticipates commencing several Phase II trials for VQD-002, Lenocta(TM) and Xyfid(TM) in the second half of 2007. In addition, VioQuest and the U.S. Army are planning to submit a New Drug Application (NDA) to the U. S. Food and Drug Administration (FDA) in 2007 for Lenocta(TM) for the treatment of leishm
'/>"/>

SOURCE VioQuest Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
4. Wisconsin firms to present at Cleantech venture capital event
5. New Sonic Foundry search engine finds words, phrases in video presentations
6. Lone Wisconsin firm to present at InvestMidwest
7. Sonic Foundry creates search engine for 7,000 expert video presentations
8. InvestMidWest calls for business presentations
9. Wicab to present BrainPort at Boston conference
10. Three more Wisconsin firms to present at venture forum
11. Six Wisconsin firms to present at BIO Mid-America VentureForum

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., ,, BOCA RATON, Fla., Nov. 25 /PRNewswire...year. Not so for BodyLogicMD. The nation,s larges... specializing exclusively in medically supervised ... physicians in its network since November 2008...to add more physician-owned centers, including one...
(Date:11/25/2009)...K, Nov. 25 Reportlinker.com announ... in its catalogue: ,, Brazil Bioethanol Market....reportlinker.com/p0165503/Brazil-Bioethanol-Marke...l Bioethanol Market Analysis and Forecasts to 2013...d analysis and forecasts of the global bioethanol ...
(Date:11/24/2009)...Nov. 24 IES (Nasdaq: IE...d communications systems and services for the comm...ced today that its commercial business group has b... install the electrical systems for the Level 4 bi....S. Army Medical Research Institute of Infectious ...
(Date:11/24/2009)...Z, Calif., Nov. 24 Two more presti...the nation,s leading online job board and careers ...stern and Columbia University are now members of t...training Institutions. ,, The job board, www.b... the life sciences. While there are hundreds of li...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2
...evelopment of Nano-Materials for Angiogenesis Appl...nn., Dec. 15 OmegaGenesis announced today that th...nic for the discovery and validation of nano-mater...Angiogenesis plays an important role in a wide var...eactivation and healing of common wounds to contro...
...System Flexibility and Efficiency to the Advanced ...nt Scanning Systems , , MELVILLE, N.Y., Dec. ...scope and software package available, Nikon Instru...es of confocal laser point scanning systems with d... imaging to life. The software, which enables ful...
...ty Trust, Inc.,(NYSE: BMR ) today announced that...ter 2008 dividend of $0.335 per share of common st...ividend of $1.34 per common share. , BioMed ...lared a dividend,of $0.46094 per share of the comp...red Stock for the period from October 16, 2008 thr...
Other Biology Technology:OmegaGenesis Announces Angiogenesis Application Collaboration 2OmegaGenesis Announces Angiogenesis Application Collaboration 3Nikon Instruments A1 Confocal Laser Microscope Series With NIS-Elements C Software Delivers Fully Integrated Comprehensive Confocal Imaging Capabilities 2Nikon Instruments A1 Confocal Laser Microscope Series With NIS-Elements C Software Delivers Fully Integrated Comprehensive Confocal Imaging Capabilities 3BioMed Realty Trust Declares Fourth Quarter 2008 Common Stock and Preferred Stock Dividends 2
(Date:11/25/2009)...WI, NOVEMBER 25, 2009 Soil is the linchpin of the...rosphere meet. Despite that, many students see soi...ing more. Soil science educators are challenged wi...ognize the critical importance of soil in the envi...nce and earth science teachers at University of Ne...
(Date:11/24/2009)...ands of years it has been prescribed by traditiona...rom headaches and stomach pain to fever and flu. ,... University have been able to scientifically prove... otherwise known as Brazilian mint. , Testing th...ed by researcher Graciela Rocha was able to show t...
(Date:11/24/2009)...at keep weakened and flabby arteries from collapsi...s, those stents are no longer needed -- once the a... Previously, doctors had no choice but to leave th...v University,s Department of Biomedical Engineerin...m that carries drugs where they,re needed, then di...
Breaking Biology News(10 mins):It's not just dirt! 2Got a pain? -- Have a cup of Brazilian mint 2A coating for life 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 6458 1Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 6458 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 6458 3Sagent Pharmaceuticals to Present at Piper Jaffray Health Care Conference 6454 1Neurobiological Technologies Announces Extraordinary Dividend of 240 18 per Share 6451 1Neurobiological Technologies Announces Extraordinary Dividend of 240 18 per Share 6451 2
...ridge, Md. (October 2, 2008) To help improve the ...peake Bay, University of Maryland Center for Envir... leading a team of scientists in a new in-depth st...r larvae go in the Choptank River. Her team,s rese...from the National Science Foundation. , Working w...
...onal beliefs about inconclusive DNA testing for he...related worry, and such beliefs are an especially ... leave the period of DNA-testing behind, reports a...ne , official journal of the American College of M...by Lippincott Williams & Wilkins, a part of Wolter...
...ineers long have known that great ideas can be lif...chers at Yale University and the National Institut... cellular level. Applying modern engineering desig...gue that artificial cells could be built that not ... eel cells but in fact improve on them. Artificial...
Other Biology News:Study looks at psychological impact of gene test for breast cancer 2Study looks at psychological impact of gene test for breast cancer 3Models of eel cells suggest electrifying possibilities 2
...is the first higher plant to be fully sequenced an...ism for gene expression research in higher plants....e ATH1 v.5 database of The Institute for Genomic R...ase at the University of Delaware. Nearly 40,000 f...
...that is designed for use with HRP conjugated rabbi... with a mouse monoclonal coating antibody. &bull...prevent non-specific binding between the coating a...y be used to stabilize newly conjugated antibodies...
Expand High Fidelity PCR System, dNTPack (Not available in US) from Roche Applied Science
Factor Xa Protease from QIAGEN
Biology Products: